Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Men Oxford Urology Library Series

The diagnosis and treatment of benign prostatic hyperplasia (BPH) is considered to be one of the most important topics in urology and afflicts millions of older men world-wide. Although it is not life threatening, its clinical manifestation as lower urinary tract symptoms (LUTS) reduces the patient's quality of life over many years. Patients often suffer from LUTS due to BPH for a long time. If left untreated, the patients are at significant risk of potentially severe complications. Over the last decade, new diagnostic approaches and treatment options such as prostate lasers have become more accepted in the urological community. This pocketbook provides an update of several aspects related with BPH / LUTS and covers the entire background, diagnostic process and treatment options available to patients suffering from LUTS due to BPH. It will give trainees in urology and general physicians a quick, concise but complete overview of diagnostic processes and recommended treatment options.

1. Definitions (LUTS, BPH, BPE, BOO, BPO). 2. Natural history of untreated BPH and its impact on LUTS. 3. Pathophysiology of BPH, symptoms and symptom scores (AUA-SI, IPSS, ICIQ-MLUTS). 4. BPH, PSA and the risk of having prostate cancer (PCA). 5. Erectile Dysfunction (ED) associated with LUTS and BPH. 6. Over-active bladder (OAB), LUTS and BPH - a paradigm shift. 7. Bladder outflow obstruction (BOO), urodynamic studies and BPH. 8. Aging men and LUTS. 9. Risk factors associated with BPH. 10. Diagnostic and assessment of BPH - subjective parameter. 11. Diagnostic and assessment of BPH - objective parameter. 12. Watchful waiting and life-style issues associated with LUTS and BPH. 13. Medical treatment of LUTS and BPH. 14. Interventional treatment of BPH. 15. Risk adapted management of BPH.

Prof. Dr. Alexander Bachmann was born in 1968 in Leipzig, Germany and earned his medical degree at Leipzig University Medical School in 1994. After residency in St. Gallen, Cologne, Zürich, Gelsenkirchen and Leverkusen he became a specialist in urology in 2002. Since April 2006 he has been the Chairman of the Department of Urology Basel-Liestal, University Hospital Basel. Dr Bachmann is specialized in trans- and retroperitoneal ablative and reconstructive laparoscopy, including donor nephrectomy. He is a founding member if the International Greenlight user group and was selected as Executive Member of BPH working group of EAU and CROES. He is an Executive Board member of the Working group Laparoscopy, Endourology and robotic-assisted Laparoscopy of the German Urological Association (DGU). His research is focused on local immunological aspects of prostate cancer, high-risk bladder cancer and emerging techniques for urinary tract infection detection, including urogenital tuberculosis. Dr de la Rosette is Professor and Chairman of the Department of Urology, at AMC University Hospital in Amsterdam, the Netherlands. He completed his medical degree and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands. He was subsequently appointed consultant urologist and Director of Minimal Invasive Urology at the Department of Urology at the St Radboud University Hospital in Nijmegen. Dr de la Rosette is the chairman of the committee on Minimal Invasive Treatment of Benign Prostatic Hyperplasia (BPH) of the International Consultation on BPH. He is also chairman of the committee on Renal Stone Disease of the International Consultation on Stone Diseases. Both consultations are patronised by the World Health Organisation (WHO). Dr de la Rosette has written over 300 peer reviewed publications and has authored many book chapters.